2400: Pre-TED

*Pre-TED Requirements
The Pre-TED (2400) Form is now required for all transplants, including subsequent transplants on the comprehensive report form track.

All transplant centers participating in CIBMTR must submit a Pre-TED (2400) Form for each allogeneic (related or unrelated) hematopoietic cell transplant (HCT). The Pre-TED is a requirement of the SCTOD for all United States transplant centers when either the stem cell donation or the transplant occurs within the United States. For more information regarding the SCTOD, see SCTOD Requirements.

Although data regarding recipients receiving autologous HCTs are not required to be submitted as part of the C.W. Bill Young Transplant Program, CIBMTR is highly committed to collecting data on these recipients for research studies. Centers choosing to report autologous data to CIBMTR must report on all autologous transplants performed at their center. For more information regarding data reporting for autologous HCT, review HCT in the Data Management Guide.

The Pre-TED may be submitted to CIBMTR up to two weeks prior to the start of the recipient’s preparative regimen (see Pre-TED (2400) Form Submission below).

The Pre-TED may be submitted to the CIBMTR up to two weeks prior to the start of the recipient’s preparative regimen (see Helpful Hint below).

*Pre-TED (2400) Form Submission
In order to avoid having to make changes to the HCT date, complete the data for the Pre-TED, but do not submit the form until the first dose of the preparative regimen is given.

!Consent Status and Baseline Forms
There has been a change to the functionality of submitting the Pre-TED (2400), Disease Classification (2402), and Pre-Cellular Therapy Essential Data (4000) forms. If a consent status has not yet been reported for a recipient, the edit form icon will appear disabled (see Figure 1 below). When the user hovers over the icon, it will display that consent has not yet been reported for that recipient (see Figure 2 below). The user should go to the Consent Tool (see Navigation to the Consent Tool) and document the recipient’s consent status in order to enable the edit icon and allow for completion of the form.

Figure 1. Disabled Edit Form Icon

Figure 2. Hovered Text, Consent Not Yet Reported

Subsequent HCTs
If a recipient receives a subsequent HCT (excluding autologous rescues and allogeneic boosts, see below) post-infusion, the form sequences will start over again with another Pre-TED (2400); this includes recipients assigned to the TED Forms and the Comprehensive Report Forms by the form selection algorithm.

For the majority of subsequent HCTs, the recipient will remain on the original follow-up form track assigned by the form selection algorithm. For more information regarding center type and the form selection algorithm, see the Data Management Guide. A recipient may need to change tracks if enrolled on a study that requires comprehensive forms.

However, if the recipient receives an autologous HCT as a result of a poor graft or graft failure or an allogeneic infusion using a prior donor for poor graft function / insufficient donor chimerism, the form sequence will not start over again . Generally, these types of infusions (autologous rescue and allogeneic boosts) are used to treat the recipient’s poor graft response, rather than to treat the recipient’s disease. The Indication for CIBMTR Data Reporting (2814) will come due for both autologous rescues and allogeneic boosts; however, after completing the form, the Donor Cellular Infusion (2199) will come only come due for allogeneic boosts.

Contact the CIBMTR Customer Service Center if the subsequent Pre-TED (2400) does not come due automatically.

For recipients of multiple transplants, completing the Indication for CIBMTR Data Reporting (2814) for the subsequent HCT will make the Pre-TED (2400) come due.

Transplant centers can use the FormsNet3^SM application to determine if a Pre-TED (2400) Form is due by either:

• Accessing the Forms Due Report, or
• Entering the recipient’s unique ID (CRID) in the Patient Forms Due field
  

Links to Sections of the Form:
Q1 – 29: Recipient Information
Q30 – 66: Donor Information
Q67 – 96: Hematopoietic Cellular Transplant (HCT) and Cellular Therapy
Q97 – 104: Clinical Status of Recipient Prior to the Preparative Regimen
Q105 – 142: Comorbidities
Q143 – 156: Pre-HCT Preparative Regimen
Q157 – 161: Additional Drugs Given in the Peri-Transplant Period
Q162 – 174: GVHD Prophylaxis
Q175 – 177: Post-HCT Disease Therapy Planned as of Day 0
Q178: Prior Exposure: Potential Study Eligibility

Manual Updates:
Sections of the Forms Instruction Manual are frequently updated. The most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.

To reference the historical Manual Change History for this form, review the retired manual section on the Retired Forms Manuals or reference the retired manual section on the Retired Forms Manuals webpage.

Date	Manual Section	Add/Remove/Modify	Description
10/24/2025	2400: Pre-TED	Modify	Version 10 of the 2400: Pre-TED section of the Forms Instruction Manual released. Version 10 corresponds to revision 11 of the Form 2400.

Copyright © 2004-2025 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.